What is the share price of Ami Organics Ltd (AMIORG) today?
The share price of AMIORG as on 21st March 2025 is ₹2423.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Ami Organics Ltd (AMIORG) share?
The past returns of Ami Organics Ltd (AMIORG) share are- Past 1 week: 8.89%
- Past 1 month: 4.27%
- Past 3 months: 14.30%
- Past 6 months: 44.00%
- Past 1 year: 117.82%
- Past 3 years: 169.65%
- Past 5 years: 159.21%
What are the peers or stocks similar to Ami Organics Ltd (AMIORG)?
The peers or stocks similar to Ami Organics Ltd (AMIORG) include:What is the dividend yield % of Ami Organics Ltd (AMIORG) share?
The current dividend yield of Ami Organics Ltd (AMIORG) is 0.11.What is the market cap of Ami Organics Ltd (AMIORG) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ami Organics Ltd (AMIORG) is ₹9920.88 Cr as of 21st March 2025.What is the 52 week high and low of Ami Organics Ltd (AMIORG) share?
The 52-week high of Ami Organics Ltd (AMIORG) is ₹2644 and the 52-week low is ₹1008.What is the PE and PB ratio of Ami Organics Ltd (AMIORG) stock?
The P/E (price-to-earnings) ratio of Ami Organics Ltd (AMIORG) is 232.07. The P/B (price-to-book) ratio is 14.53.Which sector does Ami Organics Ltd (AMIORG) belong to?
Ami Organics Ltd (AMIORG) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Ami Organics Ltd (AMIORG) shares?
You can directly buy Ami Organics Ltd (AMIORG) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Ami Organics Ltd
AMIORG Share Price
2,423.601.92% (+45.75)
AMIORG Share Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
AMIORG Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 81.74 | 14.53 | 0.11% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 50.00 | 6.39 | 0.53% |
AMIORG Analyst Ratings & Forecast
Detailed Forecast 100%
Analysts have suggested that investors can buy this stock
from 5 analysts
Price Upside
Earnings Growth
Rev. Growth
AMIORG Company Profile
AMI Organics is a manufacturer of pharmaceutical preparation.
Investor Presentation
View olderAMIORG Similar Stocks (Peers)
Compare with peersSUNPHARMA
PE Ratio
44.71
1Y Return
14.01%
Buy Reco %
88.24
CIPLA
PE Ratio
29.86
1Y Return
5.19%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
65.86
1Y Return
26.18%
Buy Reco %
68.00
DRREDDY
PE Ratio
17.93
1Y Return
2.08%
Buy Reco %
45.16
MANKIND
PE Ratio
52.09
1Y Return
13.24%
Buy Reco %
80.00
AMIORG Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
AMIORG Stock Summary · February 2025
Ami Organics Limited has demonstrated robust financial performance, with significant revenue growth driven by its CDMO and Advanced Pharmaceutical Intermediate segments, while maintaining a cautiously optimistic outlook amid market challenges. The company is strategically positioned to capitalize on opportunities in the semiconductor and electrolyte additives sectors, supported by a strong pipeline of over 570 molecules and ongoing investments in advanced technologies. Despite facing pricing pressures in the Specialty Chemicals segment, management has adapted contracts to stabilize revenue and enhance operational resilience. The focus on diversification across multiple markets, coupled with a commitment to innovation, positions the company well for sustained growth and improved margins in the coming years.
Key Points on AMIORG Stock Performance
AMIORG Stock Growth Drivers
8Strong Financial Performance
Ami Organics Limited reported impressive financial results for the first nine months of FY '25,
Growth in CDMO Business
The company anticipates its overall CDMO business to reach approximately INR 1,000 crores by FY
AMIORG Stock Challenges
4Decline in Specialty Chemical Revenue
The Specialty Chemical business has reported a revenue decline of INR 36 crores, indicating a
Challenges in Battery Chemicals Segment
The Battery Chemicals segment faces potential delays in ramp-up due to buyers awaiting approval from
AMIORG Forecasts
Price
Revenue
Earnings
AMIORG Share Price Forecast
2024
Current
₹2,423.60
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2024
Current
₹2,423.60
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
AMIORG Company Revenue Forecast
2024
Current
₹724.96
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2024
Current
₹724.96
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
AMIORG Stock EPS (Earnings Per Share) Forecast
2024
Current
₹11.66
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹
2024
Current
₹11.66
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹
AMIORG
Income
Balance Sheet
Cash Flow
Annual Normal View
AMIORG Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 156.57 | 160.47 | 191.18 | 238.89 | 242.48 | 341.99 | 522.90 | 621.05 | 724.96 | 935.84 | ||||||||||
Raw Materials | 93.58 | 94.75 | 114.72 | 151.95 | 137.96 | 174.87 | 282.33 | 345.85 | 440.17 | 733.40 | ||||||||||
| Power & Fuel Cost | 1.26 | 1.00 | 1.27 | 4.14 | 4.54 | 5.26 | 21.40 | 22.28 | 25.82 | |||||||||||
| Employee Cost | 7.02 | 7.38 | 9.89 | 8.54 | 12.95 | 21.01 | 41.37 | 48.84 | 63.11 | |||||||||||
| Selling & Administrative Expenses | 22.60 | 17.60 | 12.56 | 14.77 | 15.38 | 12.13 | 27.34 | 36.69 | 33.12 | |||||||||||
| Operating & Other expenses | 11.05 | 16.40 | 19.26 | 17.03 | 27.79 | 47.18 | 42.51 | 40.46 | 58.85 | |||||||||||
EBITDA | 21.06 | 23.34 | 33.48 | 42.46 | 43.86 | 81.54 | 107.95 | 126.93 | 103.89 | 202.44 | ||||||||||
| Depreciation/Amortization | 0.80 | 1.37 | 1.91 | 2.60 | 3.52 | 4.19 | 10.08 | 12.34 | 16.06 | 24.23 | ||||||||||
| PBIT | 20.26 | 21.97 | 31.57 | 39.86 | 40.34 | 77.35 | 97.87 | 114.59 | 87.83 | 178.21 | ||||||||||
| Interest & Other Items | 2.56 | 3.30 | 3.23 | 4.75 | 5.59 | 5.62 | 6.41 | 2.41 | 5.94 | 7.69 | ||||||||||
| PBT | 17.70 | 18.67 | 28.34 | 35.11 | 34.75 | 71.73 | 91.46 | 112.18 | 81.89 | 170.52 | ||||||||||
| Taxes & Other Items | 5.05 | 6.63 | 9.86 | 11.81 | 7.29 | 17.72 | 19.50 | 28.88 | 39.14 | 49.15 | ||||||||||
| Net Income | 12.65 | 12.04 | 18.48 | 23.30 | 27.46 | 54.01 | 71.96 | 83.30 | 42.75 | 121.37 | ||||||||||
| EPS | 4.02 | 3.82 | 5.87 | 7.40 | 8.72 | 17.15 | 21.18 | 22.86 | 11.66 | 32.91 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 3.00 | 3.00 | 3.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.13 | 0.26 | 0.09 |
AMIORG Company Updates
FY 2025
Investor Presentation
Jan 28PDF
Oct 29PDF
AMIORG Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Ami Organics Ltd | 232.07 | 14.53 | 0.11% |
| Sun Pharmaceutical Industries Ltd | 44.71 | 6.38 | 0.76% |
| Cipla Ltd | 29.86 | 4.59 | 0.85% |
| Torrent Pharmaceuticals Ltd | 65.86 | 15.91 | 0.87% |
AMIORG Stock Price Comparison
Compare AMIORG with any stock or ETFCompare AMIORG with any stock or ETF
AMIORG
AMIORG Shareholdings
AMIORG Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
AMIORG Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 1.13%
Increased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has increased by 1.65%
AMIORG Shareholding Pattern
AMIORG Shareholding History
Foreign Institutions
Mutual Funds Invested in AMIORG
A list of mutual funds holding the stock, ranked on the basis of Market-cap held which is calculated as the value of stock held in the portfolio divided by its market cap
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Ami Organics Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.5406% | Percentage of the fund’s portfolio invested in the stock 0.92% | Change in the portfolio weight of the stock over the last 3 months 0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 61/85 (-15) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.7154% | Percentage of the fund’s portfolio invested in the stock 1.94% | Change in the portfolio weight of the stock over the last 3 months 0.36% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 42/68 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.0930% | Percentage of the fund’s portfolio invested in the stock 3.27% | Change in the portfolio weight of the stock over the last 3 months 0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 13/33 (-1) |
Compare 3-month MF holding change on Screener
smallcases containing AMIORG stock
Looks like this stock is not in any smallcase yet.
AMIORG Events
AMIORG Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
AMIORG Upcoming Dividends
No upcoming dividends are available
AMIORG Past Dividends
Cash Dividend
Ex DateEx DateSep 13, 2024
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Sep 13, 2024
Cash Dividend
Ex DateEx DateSep 18, 2023
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Sep 18, 2023
Cash Dividend
Ex DateEx DateJul 29, 2022
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Jul 29, 2022
AMIORG Stock News & Opinions
Articles & Videos
Corporate
AMI Organics announces board meeting date
AMI Organics will hold a meeting of the Board of Directors of the Company on 21 February 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Ami Organics to consider stock split
The Board of Ami Organics will meet on 21 February 2025 to consider the proposal for alteration in the share capital of the Company by way of sub-division / split of the existing equity shares of the face value Rs 10/- each. Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Ami Organics edge higher after PAT soars 155% YoY to Rs 45 crore in Q3 FY25
Revenue from operations jumped 65.21% to Rs 274.98 crore in Q3 FY25 as compared with Rs 166.44 crore in Q3 FY24. Total expenses grew by 45.87% YoY to Rs 213.32 crore during the quarter. Employee benefit expenses was at Rs 21.66 crore (up 34.28% YoY). The cost of material consumed stood at Rs 157.21 crore (up 82.52% YoY). Profit before tax stood at Rs 633.34 crore in Q3 FY25, marking a growth of 167.19% as against Rs 237.03 crore posted in Q3 FY24. EBITDA stood at Rs 68.70 crore in Q3 FY25, recording the growth of 159.24% as compared with Rs 26.50 crore in Q3 FY24. EBITDA margin improved by 25% during the quarter as compared with 15.9% posted in the corresponding quarter last year. Naresh Patel, executive chairman & MD, Ami Organics, said: I am delighted to share that in the first nine months of FY25, we achieved revenue of X698 crore, nearly equalling the revenue from operations of the entire previous financial year. In Q3FY25 alone, we delivered an impressive 65.2% year-on-year growth, achieving X275 crore in revenue from operations. This performance was driven by a strong ramp-up in our CDMO business and consistent growth in advanced pharmaceutical intermediates. Our pipeline of CDMO projects is progressing well, with several initiatives nearing commercialization by FY26, solidifying the foundation for sustained long-term growth. Ongoing discussions with innovators and partners remain highly encouraging, and we are confident that the CDMO segment will see exponential growth in the coming years. With improved visibility for Q4, I am pleased to revise our FY25 growth guidance upward from 30% to 35%. This milestone reflects our unwavering commitment to delivering consistent progress, embracing adaptability, and seizing new opportunities that ensure sustainable and impactful growth.' Ami Organics is engaged in the business of drugs, intermediate chemicals, and related activities. Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Ami Organics consolidated net profit rises 168.36% in the December 2024 quarter
Net profit of Ami Organics rose 168.36% to Rs 44.95 crore in the quarter ended December 2024 as against Rs 16.75 crore during the previous quarter ended December 2023. Sales rose 65.22% to Rs 274.99 crore in the quarter ended December 2024 as against Rs 166.44 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales274.99166.44 65 OPM %24.9715.93 - PBDT69.6527.46 154 PBT63.3323.70 167 NP44.9516.75 168 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
AMI Organics to announce Quarterly Result
AMI Organics will hold a meeting of the Board of Directors of the Company on 28 January 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Ami Organics reports consolidated net profit of Rs 37.33 crore in the September 2024 quarter
Net profit of Ami Organics reported to Rs 37.33 crore in the quarter ended September 2024 as against net loss of Rs 18.85 crore during the previous quarter ended September 2023. Sales rose 43.15% to Rs 246.73 crore in the quarter ended September 2024 as against Rs 172.36 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales246.73172.36 43 OPM %19.8314.39 - PBDT56.8725.50 123 PBT50.0421.81 129 NP37.33-18.85 LP Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Ami Organics allots 6,950 equity shares under ESOS
Ami Organics has allotted 6,950 equity shares under ESOS on 14 October 2024. Pursuant to this allotment, the paid up share capital of the Company stands increased from Rs. 40,92,75,110/- (consisting of 4,09,27,511 equity shares of face value of Rs. 10/-each) to Rs. 40,93,44,610/- (consisting of 4,09,34,461 equity shares of face value of Rs. 10/- each). Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
AMI Organics to conduct AGM
AMI Organics announced that the Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
AMI Organics AGM scheduled
AMI Organics announced that the Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Ami Organics allots 21,950 equity shares under ESOS
Ami Organics has allotted 21,950 equity shares under ESOS. Pursuant to the allotment, the paid up equity share capital has increased to Rs. 40,92,75,110/- (consisting of 4,09,27,511 equity shares of face value of Rs. 10/- each). Powered by Capital Market - Live
7 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 24.86%, vs industry avg of 9.04%
Over the last 5 years, market share increased from 0.11% to 0.19%
Over the last 5 years, net income has grown at a yearly rate of 12.91%, vs industry avg of 15.27%